| Literature DB >> 25220454 |
Gunnar Hargus1, Marc Ehrlich1, Marcos J Araúzo-Bravo2, Kathrin Hemmer3, Anna-Lena Hallmann1, Peter Reinhardt4, Kee-Pyo Kim4, Kenjiro Adachi4, Simeon Santourlidis5, Foued Ghanjati5, Mareike Fauser6, Christiana Ossig6, Alexander Storch6, Jeong Beom Kim7, Jens C Schwamborn3, Jared Sterneckert4, Hans R Schöler8, Tanja Kuhlmann9, Holm Zaehres4.
Abstract
The differentiation capability of induced pluripotent stem cells (iPSCs) toward certain cell types for disease modeling and drug screening assays might be influenced by their somatic cell of origin. Here, we have compared the neural induction of human iPSCs generated from fetal neural stem cells (fNSCs), dermal fibroblasts, or cord blood CD34(+) hematopoietic progenitor cells. Neural progenitor cells (NPCs) and neurons could be generated at similar efficiencies from all iPSCs. Transcriptomics analysis of the whole genome and of neural genes revealed a separation of neuroectoderm-derived iPSC-NPCs from mesoderm-derived iPSC-NPCs. Furthermore, we found genes that were similarly expressed in fNSCs and neuroectoderm, but not in mesoderm-derived iPSC-NPCs. Notably, these neural signatures were retained after transplantation into the cortex of mice and paralleled with increased survival of neuroectoderm-derived cells in vivo. These results indicate distinct origin-dependent neural cell identities in differentiated human iPSCs both in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25220454 DOI: 10.1016/j.celrep.2014.08.014
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423